Unapproved Zika Tests Attract FDA 'Untitled' Letters
This article was originally published in The Gray Sheet
Executive Summary
Two companies and two hospitals are marketing Zika virus diagnostics without FDA go-ahead, the agency said in letters that asked the organizations for data supporting their assays.